Skip to main content

PubMed Canada to Store Government-Funded Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canada has started a national online archive that will house papers and data coming from government-funded research, and will be funded by the Canadian Institutes of Health Research.

Modeled on the National Institutes of Health's PubMed Central, the PubMed Central Canada resource was launched to provide Canadians with a free and open national digital repository of peer-reviewed health and life sciences literature, including research funded by CIHR.

PMC Canada was developed through a partnership between the National Research Council's Canada Institute for Scientific and Technical Information (NRC-CISTI), which will build the infrastructure and manage the repository, the US National Library of Medicine, and CIHR.

The resource supports the Policy on Access to Research Outputs, which requires that CIHR grant recipients make their peer-reviewed publications freely accessible online within six months after they are published.

"The global movement to provide barrier-free access to research is gaining strength and with good reason, said Ian Graham, CIHR's VP of Knowledge Translation, in a statement.

"Having desktop access to a searchable, permanent and freely accessible archive of Canadian health research will serve as a valuable resource for researchers, enabling them to translate that knowledge into solutions to important health issues," NRC-CISTI Director General Pam Bjornson added.

The first phase of PMC Canada includes development of a bilingual interface and help desk and a manuscript submission system. The planned second phase of the repository will incorporate a customized web front-end and enhanced reporting and alerting features for system funders and users.

PMC Canada's future development will be guided by an advisory committee that will include health researchers and other stakeholders.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.